THE AETIOLOGY OF CERVICAL CANCER

The contents of this document may be copied for use by staff working in the public sector but may not be copied for any other purpose without prior permission from the NHS Cancer Screening Programmes. iii The Aetiology of Cervical Cancer CONTENTS

[1]  K. Shah,et al.  Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  Y. Hirai,et al.  Serum carotenoids and vitamins and risk of cervical dysplasia from a case–control study in Japan , 1999, British Journal of Cancer.

[3]  A. Giuliano,et al.  Folate, vitamin B12, and homocysteine status. findings of no relation between human papillomavirus persistence and cervical dysplasia. , 2003, Nutrition (Burbank, Los Angeles County, Calif.).

[4]  L. Marchand,et al.  Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  F. X. Bosch,et al.  Human papillomavirus and invasive cervical cancer in Brazil. , 1994, British Journal of Cancer.

[6]  H. Pfister,et al.  State of the art regarding evidence of the viral origin of cervical cancer. , 1991, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[7]  C. Meijer,et al.  Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear , 2001, The Lancet.

[8]  A. Hare.  Transmission of human papillomaviruses from mother to child. , 1993, The Australian & New Zealand journal of obstetrics & gynaecology.

[9]  K. Syrjänen,et al.  Clinical Course and Prognostic Factors of Human Papillomavirus Infections in Men , 1994, Sexually transmitted diseases.

[10]  C. Meijer,et al.  Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction , 1990, Journal of clinical microbiology.

[11]  K. Holmes,et al.  Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. , 1998, American journal of obstetrics and gynecology.

[12]  M. Evander,et al.  The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse , 1994, Obstetrics and gynecology.

[13]  F. X. Bosch,et al.  Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. , 1996, Journal of the National Cancer Institute.

[14]  P. Howley,et al.  Transient replication of human papillomavirus DNAs , 1992, Journal of virology.

[15]  ScienceDirect.  International journal of gynaecology and obstetrics , 1969 .

[16]  J. Westerga,et al.  PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes , 2000, Journal of clinical pathology.

[17]  T. Iftner,et al.  Human papillomavirus technologies , 2003 .

[18]  Johannes Haerting,et al.  Screening for high‐grade cervical intra‐epithelial neoplasia and cancer by testing for high‐risk HPV, routine cytology or colposcopy , 2000, International journal of cancer.

[19]  E. de Villiers,et al.  Case‐control study of risk factors for cervical neoplasia in Denmark. I: Role of the “male factor” in women with one lifetime sexual partner , 2007, International journal of cancer.

[20]  C. Peyton,et al.  Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies , 1998, Journal of Clinical Microbiology.

[21]  F. X. Bosch,et al.  Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. , 1997, The Journal of infectious diseases.

[22]  K. Sotlar,et al.  Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. , 1998, Gynecologic oncology.

[23]  D. West,et al.  Genital cancer in wives of penile cancer patients , 1979, Cancer.

[24]  R. Peeling,et al.  Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study , 2004, International journal of cancer.

[25]  B. Quade,et al.  Ki-67, Cyclin E, and p16 INK4 Are Complimentary Surrogate Biomarkers for Human Papilloma Virus-Related Cervical Neoplasia , 2001, The American journal of surgical pathology.

[26]  C. Meijer,et al.  PCR‐based high‐risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears , 1996, International journal of cancer.

[27]  P. Stern,et al.  The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer , 1995, Nature Medicine.

[28]  S Wacholder,et al.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. , 1993, Journal of the National Cancer Institute.

[29]  N. Kiviat,et al.  The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. , 1996, The Journal of infectious diseases.

[30]  G. Williams,et al.  Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[32]  Y. Soong,et al.  The effect of human papillomavirus infection on sperm cell motility. , 1997, Fertility and Sterility.

[33]  M. Campion,et al.  Squamous neoplasia of the cervix in relation to other genital tract neoplasia. , 1985, Clinics in obstetrics and gynaecology.

[34]  I. Jacobs,et al.  p53 codon 72 polymorphism and risk of cervical cancer in UK , 1998, The Lancet.

[35]  L. Kalish,et al.  Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. , 1999, Journal of the National Cancer Institute.

[36]  C. Meijer,et al.  HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears , 2001, British Journal of Cancer.

[37]  C. Meyers,et al.  The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties , 1990, Journal of virology.

[38]  S. Syrjänen,et al.  Low Concordance of Genital Human Papillomavirus (HPV) Lesions and Viral Types in HPV‐Infected Women and Their Male Sexual Partners , 1994, Sexually transmitted diseases.

[39]  P. Snijders,et al.  High‐risk HPV testing in women with borderline and mild dyskaryosis: long‐term follow‐up data and clinical relevance , 2001, The Journal of pathology.

[40]  D. Lowy,et al.  High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  J. Fraumeni,et al.  Correlation between cancers of the uterine cervix and penis in China. , 1982, Journal of the National Cancer Institute.

[42]  G. Voglino,et al.  Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms , 1998, The Lancet.

[43]  K. Fleming,et al.  DNA TYPING OF GENITAL WARTS AND DIAGNOSIS OF SEXUAL ABUSE OF CHILDREN , 1987, The Lancet.

[44]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[45]  A. Giuliano,et al.  Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States) , 2002, Cancer Causes & Control.

[46]  T. Rohan,et al.  Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. , 2000, The Journal of general virology.

[47]  David R. Scott,et al.  Determinants of Genital Human Papillomavirus Infection in Low‐Risk Women in Portland, Oregon , 1993, Sexually transmitted diseases.

[48]  K. Holmes,et al.  Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. , 1997, Journal of the National Cancer Institute.

[49]  L. Brinton,et al.  The ma le factor in the etiology of cervical cancer among sexually monogamous women , 1989, International journal of cancer.

[50]  W. Quint,et al.  Technical Advance Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses , 1998 .

[51]  C. Meijer,et al.  Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression , 1998, The Lancet.

[52]  C. Peyton,et al.  Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method , 1998, Journal of Clinical Microbiology.

[53]  J. Kaldor,et al.  The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain , 1992, International journal of cancer.

[54]  K. Hemminki,et al.  Second primary cancer after in situ and invasive cervical cancer. , 2000, Epidemiology.

[55]  G. Omenn,et al.  Importance of human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  R. Hoover,et al.  Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women. , 1996, The Journal of infectious diseases.

[57]  R. Greenblatt,et al.  Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. , 1999, Journal of acquired immune deficiency syndromes.

[58]  A. Giannoudis,et al.  p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low‐ and high‐grade squamous intra‐epithelial lesions and invasive squamous carcinoma of the cervix , 1999, International journal of cancer.

[59]  R. Pierson,et al.  Human Papillomavirus DNA Detection in Sperm Using Polymerase Chain Reaction , 2001, Obstetrics and gynecology.

[60]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[61]  T. R. Broker,et al.  Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. , 1995, Genes & development.

[62]  P. Chan,et al.  Association of human papillomavirus type 58 variant with the risk of cervical cancer. , 2002, Journal of the National Cancer Institute.

[63]  G. Fleuren,et al.  Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma. , 1996, Gynecologic oncology.

[64]  C. Meyers,et al.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. , 1992, Science.

[65]  Irene M. Leigh,et al.  Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer , 1998, Nature.

[66]  R. Newton,et al.  A review of the aetiology of squamous cell carcinoma of the conjunctiva. , 1996, British Journal of Cancer.

[67]  V. Moreno,et al.  Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference , 2001, Journal of clinical pathology.

[68]  C. Herrington,et al.  Molecular events in uterine cervical cancer. , 1998, Sexually transmitted infections.

[69]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[70]  V. Beral,et al.  The spectrum of HIV‐1 related cancers in South Africa , 2000, International journal of cancer.

[71]  P. Snijders,et al.  Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance , 2002, International journal of cancer.

[72]  M. Schiffman,et al.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. , 2001, Journal of the National Cancer Institute.

[73]  C. Meijer,et al.  Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes , 1995, Journal of clinical microbiology.

[74]  K. Anastos,et al.  Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. , 2003, Journal of the National Cancer Institute.

[75]  V. Moreno,et al.  Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[76]  J. Dillner,et al.  High risk genital papillomavirus infections are not spread vertically , 1999, Reviews in medical virology.

[77]  Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. , 1996, Journal of the National Cancer Institute.

[78]  S. Garland,et al.  Epidemiological characteristics of women with high grade CIN who do and do not have human papillomavirus , 1999, British journal of obstetrics and gynaecology.

[79]  Harald zur Hausen,et al.  Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis , 2000 .

[80]  J. Walboomers,et al.  Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age‐related patterns for high‐risk and low‐risk types , 2000, International journal of cancer.

[81]  G. Fleuren,et al.  Association between HLA-expression and infiltration of immune cells in cervical carcinoma. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[82]  K. Shah,et al.  The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[83]  M. King,et al.  Male influences on cervical cancer risk. , 1986, American journal of epidemiology.

[84]  N. Kiviat,et al.  Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers. , 2001, American journal of epidemiology.

[85]  J. Best,et al.  Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants , 1995, Journal of medical virology.

[86]  S. Riethdorf,et al.  Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. , 2002, Human pathology.

[87]  J. Dillner,et al.  No serological evidence for non-sexual spread of HPV16 , 1994, The Lancet.

[88]  L. Kolonel,et al.  The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[89]  A. Haitel,et al.  p16INK4a Is a Useful Marker for the Diagnosis of Adenocarcinoma of the Cervix Uteri and Its Precursors: An Immunohistochemical Study With Immunocytochemical Correlations , 2003, The American journal of surgical pathology.

[90]  M. Follen,et al.  Why most randomized phase II cervical cancer chemoprevention trials are uninformative: lessons for the future. , 2001, Journal of the National Cancer Institute.

[91]  H. Hollema,et al.  Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. , 1996, British Journal of Cancer.

[92]  V. Moreno,et al.  Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.

[93]  K. Hemminki,et al.  Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[94]  J. Cason.  Perinatal acquisition of cervical cancer‐associated papillomaviruses , 1996, British journal of obstetrics and gynaecology.

[95]  M. Niimura,et al.  Detection of papillomavirus DNA in human semen. , 1986, Science.

[96]  S. Garland,et al.  The absence of HPV DNA in genital specimens from infants. , 1993, Genitourinary medicine.

[97]  V. Beral,et al.  International collaboration on HIV and cancer , 2000 .

[98]  M. Lehtinen,et al.  Type 1 cytokine response and treatment outcome of genital HPV lesions. , 1997, Genitourinary medicine.

[99]  A. Giuliano,et al.  Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[100]  V. Beral,et al.  Cervical cancer and use of hormonal contraceptives: a systematic review , 2003, The Lancet.

[101]  M. Plummer,et al.  Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.

[102]  R. Doll,et al.  CASE-CONTROL STUDY OF THE HUSBANDS OF WOMEN WITH DYSPLASIA OR CARCINOMA OF THE CERVIX UTERI , 1981, The Lancet.

[103]  G. Demers,et al.  The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells , 1992, Journal of virology.

[104]  F. X. Bosch,et al.  Causes of cervical cancer in the Philippines: a case-control study. , 1998, Journal of the National Cancer Institute.

[105]  G. Orth,et al.  A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. , 1998, The Journal of investigative dermatology.

[106]  R. Burk,et al.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems , 1997, Journal of clinical microbiology.

[107]  K. Egawa.  Do Human Papillomaviruses Target Epidermal Stem Cells? , 2003, Dermatology.

[108]  F. Bosch,et al.  Infección por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas , 2000 .

[109]  C. Wheeler,et al.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.

[110]  D. Lowy,et al.  The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture , 1991, Journal of virology.

[111]  R. Selik,et al.  Cancer death rates associated with human immunodeficiency virus infection in the United States. , 1998, Journal of the National Cancer Institute.

[112]  B. Lloveras,et al.  Human papillomavirus genotypes in rural Mozambique , 2001, The Lancet.

[113]  F. Wiklund,et al.  Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids. , 2000, The Journal of infectious diseases.

[114]  A. Gazdar,et al.  Aberrant methylation during cervical carcinogenesis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[115]  C. Peyton,et al.  Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. , 1994, The Journal of infectious diseases.

[116]  J. Palefsky,et al.  Cervical and anal HPV infections in HIV positive women and men. , 2002, Virus research.

[117]  M. Abba,et al.  Association of human papillomavirus viral load with HPV16 and high‐grade intraepithelial lesion , 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[118]  F. Vela,et al.  Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[119]  G. Jin,et al.  Malignant transformation of HPV 16‐immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis , 1996, International Journal of Cancer.

[120]  H. Hollema,et al.  Homozygous arginine-72 in wild type p53 and risk of cervical cancer , 1998, The Lancet.

[121]  E. Franco,et al.  Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. , 1995, The Journal of infectious diseases.

[122]  L. Wilkens,et al.  Case‐control study of plasma folate, homocysteine, vitamin B12, and cysteine as markers of cervical dysplasia , 2000, Cancer.

[123]  A. Hildesheim,et al.  Host and viral genetics and risk of cervical cancer: a review. , 2002, Virus research.

[124]  H. Adami,et al.  Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.

[125]  D. Venzon,et al.  Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. , 1997, Journal of the National Cancer Institute.

[126]  A. Kaufmann,et al.  HPV induced cervical carcinogenesis: molecular basis and vaccine development , 2002, Zentralblatt fur Gynakologie.

[127]  P. Stern,et al.  Loss of MHC class‐I expression in cervical carcinomas , 1990, International journal of cancer.

[128]  M. J. Whitley,et al.  Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoring , 2004, Journal of medical virology.

[129]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[130]  A. Moscicki,et al.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. , 2001, JAMA.

[131]  M. Melbye,et al.  HPV detection in children prior to sexual debut , 1997, International journal of cancer.

[132]  R. Hiatt,et al.  Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. , 1999, JAMA.

[133]  S Wacholder,et al.  HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. , 2000, JAMA.

[134]  J. Gray,et al.  Detection of human papillomavirus DNA on the fingers of patients with genital warts. , 1999, Sexually transmitted infections.

[135]  N. Dyson.  The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[136]  E. Leão,et al.  Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. , 1994, Gynecologic oncology.

[137]  N. Kiviat,et al.  Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. , 2001, American journal of epidemiology.

[138]  Lilienfeld Am,et al.  Carcinoma of the cervix in Jewish women in Israel, 1960-67. An epidemiological study. , 1971, Israel journal of medical sciences.

[139]  J. Kaldor,et al.  Risk factors for cervical cancer in Colombia and Spain , 1992, International journal of cancer.

[140]  P. Gravitt,et al.  Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. , 1992, IARC scientific publications.

[141]  R. Burk,et al.  Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia , 1998, International journal of cancer.

[142]  C. Meijer,et al.  HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection. , 1993, European journal of cancer.

[143]  Valerie Beral,et al.  Human immunodeficiency virus infection and cancer , 1998 .

[144]  J. Mandelblatt,et al.  Is HIV infection a cofactor for cervical squamous cell neoplasia? , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[145]  C. Meijer,et al.  Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis. , 2002, The American journal of pathology.

[146]  J. Dillner,et al.  A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children , 1999, International journal of cancer.

[147]  N. Muñoz,et al.  Risk Factors for HPV DNA Detection in Middle‐Aged Women , 1996, Sexually transmitted diseases.

[148]  G. Stringel,et al.  Genital warts in children. , 1985, Canadian Medical Association journal.

[149]  P. Lazo,et al.  The molecular genetics of cervical carcinoma , 1999, British Journal of Cancer.

[150]  L. Brinton,et al.  Determinants of Genital Human Papillomavirus Infection in Low‐Income Women in Washington, D.C , 1993, Sexually transmitted diseases.

[151]  L Beardsley,et al.  Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.

[152]  X. Castellsagué,et al.  The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence , 2005, International journal of cancer.

[153]  A. Bergman,et al.  Prevalence of human papillomavirus infection in men. Comparison of the partners of infected and uninfected women. , 1992, The Journal of reproductive medicine.

[154]  A. Giuliano,et al.  Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[155]  N. Muñoz,et al.  Human papillomavirus infection and invasive cervical cancer in Paraguay , 2000, International journal of cancer.

[156]  Karl Münger,et al.  Human papillomavirus immortalization and transformation functions. , 2002, Virus research.

[157]  E. Hajek.  Contribution to the Etiology of Laryngeal Papilloma in Children , 1956, The Journal of Laryngology & Otology.

[158]  K. Shah,et al.  Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women , 1997, Clinical and diagnostic laboratory immunology.

[159]  S. Garland,et al.  The Absence of Genital Human Papillomavirus DNA in Virginal Women , 1992, International journal of STD & AIDS.

[160]  J. Cuzick,et al.  Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. , 1994, British Journal of Cancer.

[161]  A. Schneider,et al.  Identification of a new proliferation‐associated protein NET‐1/C4.8 characteristic for a subset of high‐grade cervical intraepithelial neoplasia and cervical carcinomas , 2002, International journal of cancer.

[162]  H. S. Kim,et al.  Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[163]  Genital human papillomavirus infection in female university students as determined by a PCR-based method. , 1991, JAMA.

[164]  Eto,et al.  THE NEW ENGLAND JOURNAL OF MEDICINE , 1977, The Lancet.

[165]  Y. Harima,et al.  Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women. , 2001, International Journal of Molecular Medicine.

[166]  C. Meijer,et al.  The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months , 1995, International journal of cancer.

[167]  R. Cartwright,et al.  CARCINOMA OF PENIS AND CERVIX , 1980, The Lancet.

[168]  F. X. Bosch,et al.  Cancer incidence correlations: Genital, urinary and some tobacco‐related cancers , 1990, International journal of cancer.

[169]  S. Kjaer,et al.  Human Papillomavirus Infection in Danish Female Sex Workers: Decreasing Prevalence With Age Despite Continuously High Sexual Activity , 2000, Sexually transmitted diseases.

[170]  F. Wiklund,et al.  Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. , 1999, The Journal of general virology.

[171]  B. Johansson,et al.  Human papillomavirus deoxyribonucleic acid in cervix only detected in girls after coitus , 1996, International journal of STD & AIDS.

[172]  David R. Scott,et al.  A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix. , 1998, Nutrition and cancer.

[173]  J. Cuzick,et al.  Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical cancer , 1992, The Lancet.

[174]  A. Halpern,et al.  Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments , 1995, Journal of virology.

[175]  V. Beral.  Cancer of the cervix: a sexually transmitted infection? , 1974, Lancet.

[176]  I. Catalá,et al.  Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain , 2003, Sexually transmitted diseases.

[177]  M. von Knebel Doeberitz,et al.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. , 1988, Cancer research.

[178]  P. Coursaget,et al.  Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes , 2001, Journal of Clinical Microbiology.

[179]  C. Clavel,et al.  Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women , 1999, British Journal of Cancer.

[180]  V. Pravica,et al.  Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL‐10 production , 2001, International journal of cancer.

[181]  F. X. Bosch,et al.  Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[182]  P. Stern,et al.  Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. , 1995, British Journal of Cancer.

[183]  F. X. Bosch,et al.  Risk factors for cervical cancer in Thailand: a case-control study. , 1998, Journal of the National Cancer Institute.

[184]  David R. Scott,et al.  A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. , 2002, Journal of the National Cancer Institute.

[185]  F. Z. Zarama Márquez,et al.  [Risk factors for cervical cancer]. , 2003, Ginecologia y obstetricia de Mexico.

[186]  N. Muñoz,et al.  HPV and cervical adenocarcinoma: an IARC based multicentric case-control study , 2000 .

[187]  E. Benton,et al.  Papillomavirus reviews: Current research on papillomaviruses , 1996 .

[188]  E. Franco,et al.  Human papillomavirus testing for primary screening of cervical cancer precursors. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[189]  P. V. van Diest,et al.  Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age‐dependent , 2009, International journal of cancer.

[190]  Y. Nakamura,et al.  No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. , 1998, Cancer research.

[191]  T. Wright,et al.  HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. , 2000, JAMA.

[192]  I. Nindl,et al.  Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra‐epithelial neoplasia and cervical cancer , 1999, International journal of cancer.

[193]  T. Rohan,et al.  Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. , 1999, The Journal of infectious diseases.

[194]  M. Bibbo,et al.  P16INK4A as an adjunct test in liquid-based cytology. , 2003, Analytical and quantitative cytology and histology.

[195]  H. Adami,et al.  Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.

[196]  M. Chiasson,et al.  Incidence of cervical squamous intraepithelial lesions in HIV-infected women. , 2000, JAMA.

[197]  E. Wilander,et al.  Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. , 1998, Cancer research.

[198]  T. Rohan,et al.  A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[199]  G. Bastert,et al.  Immunocytochemical Detection of HPV High-Risk Type L1 Capsid Proteins in LSIL and HSIL as Compared with Detection of HPV L1 DNA , 2003, Acta Cytologica.

[200]  J. Nevins,et al.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[201]  J. Cuzick,et al.  Effect of smoking cessation on cervical lesion size , 1996, The Lancet.

[202]  David R. Scott,et al.  Viral load of human papillomavirus and risk of CIN3 or cervical cancer , 2002, The Lancet.

[203]  A. Giuliano,et al.  Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. , 2003, The Journal of infectious diseases.

[204]  M. Schiff,et al.  Dietary micronutrients and cervical dysplasia in southwestern American Indian women. , 1992, Nutrition and cancer.

[205]  N. Muñoz,et al.  Epidemiology of HPV infection among Mexican women with normal cervical cytology , 2001, International journal of cancer.

[206]  C. Paul,et al.  IMPORTANCE OF THE MALE FACTOR IN CANCER OF THE CERVIX , 1982, The Lancet.

[207]  S. Wacholder,et al.  HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica , 2001, British Journal of Cancer.

[208]  M. Plummer,et al.  Prevalence and determinants of human papillomavirus genital infection in men , 2002, British Journal of Cancer.

[209]  H. B. Lim,et al.  In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[210]  D. Vlahov,et al.  Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. , 2000, American journal of epidemiology.

[211]  M. Sherman,et al.  Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[212]  F. X. Bosch,et al.  Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[213]  A. Saqi,et al.  Overexpression of p16INK4A in liquid‐based specimens (SurePath™) as marker of cervical dysplasia and neoplasia , 2002, Diagnostic cytopathology.

[214]  P. Coursaget,et al.  Risk factors of invasive cervical cancer in Mali. , 2002, International journal of epidemiology.

[215]  L. Laimins,et al.  Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. , 1998, Virology.

[216]  D. Lowy,et al.  Papillomavirus is resistant to desiccation. , 1997, The Journal of infectious diseases.

[217]  C. Peyton,et al.  Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF10 Line Probe Assay , 2002, Journal of Clinical Microbiology.

[218]  M. Lehtinen,et al.  Stability over time of serum antibody levels to human papillomavirus type 16. , 1998, The Journal of infectious diseases.

[219]  J. Dillner,et al.  Identification of human papillomavirus seroconversions. , 1995, The Journal of general virology.

[220]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[221]  M. Lizano,et al.  Association between human papillomavirus type 18 variants and histopathology of cervical cancer. , 1997, Journal of the National Cancer Institute.

[222]  A. Vaheri,et al.  Human Papillomavirus in Larynx , 2002, The Laryngoscope.

[223]  C. Meijer,et al.  Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study , 1999, The Lancet.

[224]  M. Serrano.  The tumor suppressor protein p16INK4a. , 1997, Experimental cell research.

[225]  I. I. Kessler.  Venereal factors in human cervical cancer. Evidence from marital clusters , 1977, Cancer.

[226]  H. Adami,et al.  A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. , 2000, Cancer research.

[227]  E. Kucera,et al.  Papilloma virus and c-erbB-2 expression in diseases of the mammary nipple. , 2001, Anticancer research.

[228]  A. Ciechanover,et al.  Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[229]  M. Lehtinen,et al.  Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. , 1996, The Journal of infectious diseases.

[230]  D. DiMaio,et al.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[231]  Wim Quint,et al.  Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus , 1999, Journal of Clinical Microbiology.

[232]  H Peng,et al.  Human papillomavirus DNA is present in a subset of unselected breast cancers. , 2001, Journal of human virology.

[233]  M. Schymura,et al.  Cancer incidence in New York State acquired immunodeficiency syndrome patients. , 2001, American journal of epidemiology.

[234]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[235]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[236]  Claude Fauquet,et al.  Classification of papillomaviruses. , 2004, Virology.

[237]  M. O’Donovan,et al.  p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep™ smears , 2003, Journal of clinical pathology.

[238]  L. Laimins.  Human papillomaviruses target differentiating epithelia for virion production and malignant conversion , 1996 .

[239]  P. Fuchs,et al.  Anatomy, taxonomy and evolution of papillomaviruses. , 1994, Intervirology.

[240]  R. Burk,et al.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. , 1995, Journal of the National Cancer Institute.

[241]  I. Martínez,et al.  Relationship of squamous cell carcinoma of the cervix uteri to squamous cell carcinoma of the penis. Among Puerto Rican women married to men with penile carcinoma , 1969, Cancer.

[242]  S. Koi,et al.  Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. , 1989, Virology.

[243]  S. Syrjänen,et al.  Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. , 1996, American journal of obstetrics and gynecology.

[244]  S. de Sanjosé,et al.  Prevalence of HPV cervical infections among imprisoned women in Barcelona, Spain , 2000, Sexually transmitted infections.

[245]  C. Meijer,et al.  Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. , 2000, The Journal of general virology.

[246]  J. Dillner,et al.  Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. , 1996, Virology.

[247]  J. Goedert,et al.  Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. , 2000, Journal of the National Cancer Institute.

[248]  D. Lowy,et al.  Identification of the HPV‐16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. , 1987, The EMBO journal.

[249]  F. X. Bosch,et al.  Prostitution, HIV, and cervical neoplasia: a survey in Spain and Colombia. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[250]  A. Giuliano,et al.  Antioxidant nutrients: associations with persistent human papillomavirus infection. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[251]  V. Beral,et al.  The epidemiology of conjunctival squamous cell carcinoma in Uganda , 2002, British Journal of Cancer.

[252]  A. Tanigami,et al.  Human papillomavirus type 33 dna in breast cancer in Chinese , 2000, Breast cancer.

[253]  P. Fuchs,et al.  Human papillomavirus 16 dna in cervical cancers and in lymph nodes of cervical cancer patients: A diagnostic marker for early metastases? , 1989, International journal of cancer.

[254]  J. Handley,et al.  Anogenital warts in prepubertal children: pathogenesis, HPV typing and management , 1997, International journal of STD & AIDS.

[255]  J. Paavonen,et al.  Human Papillomavirus DNA is Not Transmitted by Semen , 1991, International journal of STD & AIDS.

[256]  G. Voglino,et al.  p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. , 2001, Cancer research.

[257]  P. Chan,et al.  Blastocysts exhibit preferential uptake of DNA fragments from the E6-E7 conserved region of the human papillomavirus. , 1995, Gynecologic oncology.

[258]  J. Dillner,et al.  Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection , 1995, Journal of medical virology.

[259]  Karl Münger,et al.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein , 2001, Oncogene.

[260]  M. Kosorok,et al.  Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. , 1995, The Journal of infectious diseases.

[261]  Chieh-Yu Lin,et al.  Possible transplacental transmission of human papillomaviruses. , 1992 .

[262]  J. Best,et al.  Human papillomavirus type 16 in infants: use of DNA sequence analyses to determine the source of infection. , 1996, The Journal of general virology.

[263]  S. Franceschi,et al.  Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. , 2002, Journal of the National Cancer Institute.

[264]  K. Holmes,et al.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection , 1992, The New England journal of medicine.

[265]  C. Wheeler,et al.  Human Papillomavirus: A Highly Prevalent Sexually Transmitted Disease Agent Among Female Sex Workers From Mexico City , 2001, Sexually transmitted diseases.

[266]  J. Schiller,et al.  Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children. , 1997, Intervirology.

[267]  David R. Scott,et al.  Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer , 2003, Journal of Clinical Microbiology.

[268]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[269]  J. Satagopan,et al.  Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. , 2003, Journal of the National Cancer Institute.

[270]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[271]  J. Dillner,et al.  Comparison of Development of Serum Antibodies to HPV16 and HPV33 and Acquisition of Cervical HPV DNA Among Sexually Experienced and Virginal Young Girls: A Longitudinal Cohort Study , 1996, Sexually transmitted diseases.

[272]  L. Banks,et al.  The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.

[273]  N. Muñoz,et al.  HPV types and cofactors causing cervical cancer in Peru , 2001, British Journal of Cancer.

[274]  C. Meijer,et al.  TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. , 2004, Journal of the National Cancer Institute.

[275]  L. Turek,et al.  Perinatal transmission and maternal risks of human papillomavirus infection. , 1995, Cancer detection and prevention.

[276]  G. Williams,et al.  Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[277]  P. Lake,et al.  Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. , 1987, Journal of the National Cancer Institute.

[278]  A. van Assche,et al.  Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. , 1995, Gynecologic and obstetric investigation.

[279]  J. Cuzick,et al.  PROGRESSIVE POTENTIAL OF MILD CERVICAL ATYPIA: PROSPECTIVE CYTOLOGICAL, COLPOSCOPIC, AND VIROLOGICAL STUDY , 1986, The Lancet.

[280]  N. Muñoz,et al.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. , 2003, Journal of the National Cancer Institute. Monographs.

[281]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[282]  A. Hakura,et al.  Detection of high-risk human papillomavirus in the cervix and semen of sex partners. , 1994, The Journal of infectious diseases.

[283]  J. Bourhis,et al.  Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA , 1990, The Lancet.

[284]  P. Rous.  Transmission of a malignant new growth by means of a cell-free filtrate. , 1973, Connecticut medicine.

[285]  S. Vernon,et al.  Comparison of Human Papillomavirus Detection and Typing by Cycle Sequencing, Line Blotting, and Hybrid Capture , 2000, Journal of Clinical Microbiology.

[286]  J. Cuzick,et al.  A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions , 2000, British Journal of Cancer.

[287]  R. Gornall,et al.  p53 polymorphism and risk of cervical cancer , 1998, The Lancet.

[288]  N. Muñoz,et al.  The viral origin of cervical cancer in Rabat, Morocco , 1998, International journal of cancer.

[289]  S. Franceschi,et al.  Risk of invasive cervical cancer among women with, or at risk for, HIV infection , 1999, International journal of cancer.

[290]  Attila Lorincz,et al.  Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[291]  W. Reeves,et al.  Human Papillomavirus (HPV) DNA Copy Number Is Dependent on Grade of Cervical Disease and HPV Type , 1999, Journal of Clinical Microbiology.

[292]  J. Dillner,et al.  Correlates of the spread of human papillomavirus infection. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[293]  M. von Knebel Doeberitz,et al.  No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer , 1999, Journal of Molecular Medicine.

[294]  C. Meijer,et al.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings , 1997, Journal of clinical microbiology.

[295]  J. Walboomers,et al.  IMMUNOGENETIC FACTORS IN HPV‐ASSOCIATED CERVICAL CANCER: INFLUENCE ON DISEASE PROGRESSION , 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[296]  C. Wheeler,et al.  Determinants of Genital Human Papillomavirus Infection Among Cytologically Normal Women Attending the University of New Mexico Student Health Center , 1993, Sexually transmitted diseases.

[297]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[298]  F. X. Bosch,et al.  Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[299]  M. von Knebel Doeberitz,et al.  Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri , 2001, International journal of cancer.

[300]  M. Sherman,et al.  Different risk factor patterns for high‐grade and low‐grade intraepithelial lesions on the cervix among HPV‐positive and HPV‐negative young women , 1998, International journal of cancer.

[301]  C. Peyton,et al.  Determinants of genital human papillomavirus detection in a US population. , 2001, The Journal of infectious diseases.

[302]  Y. Barrandon,et al.  The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells , 1996, Journal of virology.

[303]  M. Schiffman,et al.  Determinants of genital human papillomavirus infection in young women. , 1991, Journal of the National Cancer Institute.

[304]  S. Franceschi,et al.  Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. , 1998, British Journal of Cancer.

[305]  D. Tredway,et al.  Human papillomavirus gene sequences in washed human sperm deoxyribonucleic acid. , 1994, Fertility and sterility.

[306]  R. Burk,et al.  Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential , 1995, International journal of cancer.

[307]  T. Iftner,et al.  Interference of papillomavirus E6 protein with single‐strand break repair by interaction with XRCC1 , 2002, The EMBO journal.

[308]  A. Børresen-Dale,et al.  An increased risk of cervical intra‐epithelial neoplasia grade II‐III among human papillomavirus positive patients with the HLA‐DQA1*0102‐DQB1*0602 haplotype: A population‐based case–control study of Norwegian women , 1998, International journal of cancer.

[309]  J. Peto,et al.  Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort , 2000, British Journal of Cancer.

[310]  M. Evander,et al.  Lifetime Number of Partners As the Only Independent Risk Factor for Human Papillomavirus Infection: A Population‐Based Study , 1995, Sexually transmitted diseases.

[311]  Y. Soong,et al.  Perinatal Transmission of Human Papillomavirus in Infants: Relationship Between Infection Rate and Mode of Delivery , 1998, Obstetrics and gynecology.

[312]  A. Adelstein,et al.  Mortality of wives of men dying with cancer of the penis. , 1980, British Journal of Cancer.

[313]  M. Van Ranst,et al.  Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. , 1992, The Journal of general virology.

[314]  J. Icenogle,et al.  A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA , 1997, Journal of clinical microbiology.

[315]  T. Rohan,et al.  Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. , 2001, JAMA.

[316]  M. Stanley,et al.  Human papillomaviruses and cervical cancer : biology and immunology , 1994 .

[317]  V. Giaché,et al.  Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. , 1997, Journal of clinical pathology.

[318]  A. Ferenczy,et al.  Underwear: contamination by human papillomaviruses. , 1990, American journal of obstetrics and gynecology.

[319]  J. Cuzick,et al.  Human papillomavirus testing in primary cervical screening , 1995, The Lancet.

[320]  V. Cogliano.  International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.

[321]  N. Kiviat,et al.  Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. , 2001, American journal of epidemiology.

[322]  C. Woodman,et al.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study , 2001, The Lancet.